Advertisement
Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

Ruby+Associates Completes Latest Mercy Health Systems Design-Build Project

August 9, 2011 7:46 am | by Bio-Medicine.Org | News | Comments

FARMINGTON HILLS, Mich., Aug. 9, 2011 /- Ruby+Associates, the constructability-focused structural engineering firm, has completed its design-build assignment for Mercy Health Systems' Willard Hospital project in Willard, OH.  Ruby acted as the engineer of record on the 105,000 sq ft...

Scientific Presentations at 2011 AAPM/COMP Meeting Highlight TrueBeam® and RapidArc® Radiotherapy Systems From Varian Medical Systems

August 9, 2011 5:38 am | by Bio-Medicine.Org | News | Comments

VANCOUVER, British Columbia, Aug. 9, 2011 /- Medical physicists researching RapidArc® radiotherapy technology from Varian Medical Systems (NYSE: VAR ) have reported that, compared with conventional approaches to radiotherapy, RapidArc treatment plans for lung, abdominal and spinal...

United Kingdom Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

August 9, 2011 4:43 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Aug. 9, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: United Kingdom Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others...

Advertisement

MedShape Solutions Announces FDA 510(k) Clearance of Innovative Ankle Fusion Device

August 9, 2011 4:43 am | by Bio-Medicine.Org | News | Comments

ATLANTA, Aug. 9, 2011 /- MedShape Solutions, Inc., the industry leader in innovative shape memory orthopedic devices, today announced its new DynaNail™ Intramedullary Ankle Fusion Nail. Ankle fusion is performed to relieve pain in patients with severely degenerative ankle joints, to...

Medical Equipment Quarterly Deals Analysis: M & A and Investment Trends - Q2 2011

August 9, 2011 4:40 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Aug. 9, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Medical Equipment Quarterly Deals Analysis: M&A and Investment Trends - Q2 2011...

DNA and RNA Probes: Preparation, Formats, Labeling, Amplification, Detection

August 9, 2011 4:39 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Aug. 9, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: DNA and RNA Probes: Preparation, Formats, Labeling, Amplification, Detection...

Marken Announces Appointment of Christopher O'Connell as New Chief Financial Officer

August 9, 2011 4:38 am | by Bio-Medicine.Org | News | Comments

LONDON, Aug. 9, 2011 /- Marken Ltd., a leading life sciences supply chain management organization, today announced the appointment of Christopher O'Connell as their new Chief Financial Officer (CFO) effective August 1, 2011. Mr. O'Connell joins Marken with more than 20 years experience in...

Boston Scientific Announces Favorable Court Ruling Dismissing Securities Fraud Case

August 8, 2011 1:44 pm | by Boston Scientific | News | Comments

NATICK, Mass., Aug. 8, 2011 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announces the U.S. Court of Appeals for the First Circuit has affirmed the dismissal of a securities fraud case in connection with th

Advertisement

PositiveID Corporation Appoints Pietro Galassetti, MD, PhD to Its Scientific Advisory Board

August 8, 2011 12:38 pm | by PositiveID | News | Comments

PositiveID Corporation Appoints Pietro Galassetti, MD, PhD to Its Scientific Advisory Board

HeartWare to Present at the Canaccord Genuity 31st Annual Growth Conference

August 8, 2011 11:42 am | by Bio-Medicine.Org | News | Comments

FRAMINGHAM, Mass. and SYDNEY, Aug. 8, 2011 /- HeartWare International, Inc. (NASDAQ: HTWR ; ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug...

Global Health Ventures August 4th Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com

August 8, 2011 11:41 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Aug. 8, 2011 /- Global Health Ventures Inc. (OTCBB: GHLV), a specialty pharmaceutical company with focus on sublingual drug delivery announced today that their August 4th RetailInvestorConferences.com presentation by Dr. Hassan Salari PhD, Chairman and CEO, is available for...

Reducing Tube Current to Manage CT Radiation Dose

August 8, 2011 11:40 am | by Diagnostic Imaging | News | Comments

Using lower fixed-tube current or automatic exposure control techniques when performing adult and pediatric head CT scans can reduce radiation dose and ease concern about cancer risk, according to a recent study published in the Journal of the American College of Radiology.

Caliper, Carestream settle infringement lawsuits

August 8, 2011 9:38 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Caliper Life Sciences Inc., a Hopkinton drug discovery firm, has settled two patent infringement lawsuits with Rochester, N.Y.-based Carestream Health Inc.

Advertisement

Symphony Corporation Acquires JGI to Provide End-to-End Services for Healthcare IT

August 8, 2011 8:47 am | by Bio-Medicine.Org | News | Comments

MADISON, Wis., Aug. 8, 2011 /- Symphony Corporation, a global healthcare technology solutions provider, today announced the acquisition of JGI, a New Jersey-based Human Capital Management consulting and technology firm with a significant presence in the healthcare industry nationally....

Endologix Announces First U.S. Implant of AFXâ„¢ Endovascular AAA System

August 8, 2011 8:47 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Aug. 8, 2011 /- Endologix, Inc. (Nasdaq: ELGX ), developer and marketer of minimally invasive treatments for aortic disorders, announced today that the first U.S. commercial implant of the Company's AFX™ Endovascular AAA System was performed at Edward Hines, Jr. VA...

Auxilium Pharmaceuticals, Inc. Announces Promotion of Dr. James P. Tursi to Chief Medical Officer

August 8, 2011 8:46 am | by Bio-Medicine.Org | News | Comments

MALVERN, Pa., Aug. 8, 2011 /- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL ), a specialty biopharmaceutical company, today announced that Dr. James P. Tursi has been promoted to Chief Medical Officer. Dr. Tursi will report to Armando Anido, Chief Executive Officer and President of...

Spaulding Clinical Announces New Joint Partnership for Global Studies with Eurofins Optimed Clinical Research

August 8, 2011 8:46 am | by Bio-Medicine.Org | News | Comments

WEST BEND, Wis., Aug. 8, 2011 /- Eurofins Optimed Clinical Research, an experienced European clinical research service provider and Spaulding Clinical Research, LLC., US-based, leading-edge Clinical Pharmacology, Cardiac Core Lab, and Medical Device Manufacturer, announce a joint...

Carrot Medical Positioned for Third Straight Year of Triple Digit Growth

August 8, 2011 8:46 am | by Bio-Medicine.Org | News | Comments

BOSTON, Aug. 8, 2011 /- Carrot Medical, a leading manufacturer of integrated medical imaging display and communication systems, has announced results for Q2 2011. During the year, Carrot Medical achieved significant growth in sales and an expansion of sales channels. Concluding the first...

PET Parses Alzheimer's, Other Cognitive Impairments

August 8, 2011 8:43 am | by Diagnostic Imaging | News | Comments

Positron emission tomography (PET) scans using F-18 florbetaben (18F-FDG) clearly distinguished patients with Alzheimer's disease from those with frontaltemporal lobar degeneration (FTLD) and other cognitive impairments, according to a study in the Journal of Nuclear Medicine.

Saladax Biomedical, Inc. Enters Agreement with Kaan Medikal for Distribution of My5-FU in Turkey

August 8, 2011 8:43 am | by Bio-Medicine.Org | News | Comments

BETHLEHEM, Pa., Aug. 8, 2011 /- Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized medicine for new and existing therapeutics, announced today that Kaan Medikal will serve as the exclusive...

Alere bumps up its stake in Axis-Shield stock

August 8, 2011 6:39 am | by Mass High Tech: The Journal of New England Technology | News | Comments

After confirming Friday its $375 million offer to acquire the outstanding shares of Scottish life sciences company Axis-Shield Plc, Waltham-based Alere Inc. announced today that it has increased its ownership stake of the company's shares from 2.23 percent to 6.4 percent.

Caliper and Carestream Settle Lawsuits

August 8, 2011 6:39 am | by Bio-Medicine.Org | News | Comments

HOPKINTON, Mass., Aug. 8, 2011 /- Caliper Life Sciences, Inc. (NASDAQ: CALP ) today announced that it has favorably settled two lawsuits with Carestream Health, Inc. In the first lawsuit, filed in February 2010, Caliper, its wholly owned subsidiary, Xenogen, and Stanford University...

Cardica to Present at the Wedbush Life Sciences Management Access Conference

August 8, 2011 5:39 am | by Bio-Medicine.Org | News | Comments

REDWOOD CITY, Calif., Aug. 8, 2011 /- Cardica, Inc. (Nasdaq: CRDC ) today announced that Bernard A. Hausen, M.D., Ph.D., the company's president and chief executive officer, is scheduled to present a corporate overview and update at the Wedbush 2011 Life Sciences Management Access...

Researchers Find RapidArc® Radiotherapy from Varian Medical Systems Can Quickly and Accurately Deliver Total Marrow Irradiation (TMI) Treatments for Patients with Blood Cance...

August 8, 2011 5:38 am | by Bio-Medicine.Org | News | Comments

PALO ALTO, Calif., Aug. 8, 2011 /- RapidArc® radiotherapy from Varian Medical Systems (NYSE: VAR ) can be used to treat patients with blood cancers by quickly and accurately delivering "clinically favorable" total marrow irradiation (TMI), according to a team of noted cancer...

Abaxis Announces Stock Repurchase Program

August 8, 2011 5:38 am | by Bio-Medicine.Org | News | Comments

UNION CITY, Calif., Aug. 8, 2011 /- ABAXIS, Inc. (Nasdaq: ABAX ) today announced that its Board of Directors has approved the repurchase of up to an aggregate of $40,000,000 of its Common Stock.  The repurchases will be made from time to time on the open market at prevailing market...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading